Business
Xtant Medical Announces the Launch of OsteoFactor Pro™
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and wound care disorders, today announced the commercial launch of OsteoFactor Pro™, a naturally occurring cocktail of allogeneic growth factors engineered to improve bone healing and support surgical success across orthopedic and spine procedures.
About this update from Xtant Medical Holdings, Inc.
[{"type":"text","content":"Allogeneic Growth Factor Solution to Accelerate Bone Repair","length":59,"tagName":"p","attribs":{}},{"type":"text","content":"BELGRADE, Mont., May 28, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and wound care disorders, today announced the commercial launch of OsteoFactor Pro™, a naturally occurring cocktail of allogeneic growth factors engineered to improve bone healing and support surgical success across orthopedic and spine procedures.","length":457,"tagName":"p"},{"type":"text","content":"OsteoFactor Pro™ is a naturally derived, growth factor-rich formulation that enhances the biologic activity and regenerative potential of any orthobiologic scaffold. Its biphasic release profile—delivering an immediate bolus followed by sustained growth factor release—is designed to drive and stimulate the body's key natural bone regeneration pathways including targeted angiogenesis, chemotaxis, and osteogenesis throughout the healing process.","length":451,"tagName":"p"},{"type":"text","content":"OsteoFactor Pro™ is an off-the-shelf, ready-to-use solution that integrates seamlessly with synthetic, allograft, or autograft scaffolds. It provides surgeons with exceptional versatility and biologic performance to support a wide range of bone regeneration approaches.","length":269,"tagName":"p"},{"type":"text","content":"OsteoFactor Pro™ is now available to Xtant Medical's nationwide distribution network.","length":89,"tagName":"p"},{"type":"text","content":""This product reflects our commitment to advancing the science of healing through biologics that offer precision, flexibility, and meaningful clinical impact," said Sean Browne, President and CEO of Xtant Medical.","length":223,"tagName":"p"},{"type":"text","content":"Mark Schallenberger, COO of Xtant Medical added, "With the launch of OsteoFactor Pro™, Xtant becomes the first vertically integrated company to offer solutions across all five major orthobiologic categories—demineralized bone matrix, cellular allografts, synthetics, structural allografts, and now growth factors. This milestone reflects our long-term commitment to innovation, scalability, and meeting the full spectrum of surgeon and patient needs in regenerative medi...